AESCULAP, INC

AESCULAP, INC specializes in the design, manufacturing, and distribution of advanced medical devices and surgical instrumentation, primarily serving the healthcare and biomedical sectors. Their technical expertise centers on precision-engineered surgical tools, minimally invasive device systems, and sterile-ready medical components compliant with FDA regulations and ISO 13485 quality standards. The company’s capabilities include high-precision machining, biocompatible material selection, and sterile packaging solutions tailored for hospital and clinical environments. Their focus on reliability, reproducibility, and regulatory adherence distinguishes them in the medical device supply chain, particularly for procedures requiring consistent performance under stringent clinical conditions. Award history is not available to confirm specific agency engagements, so no definitive patterns of government contracting activity can be identified. While AESCULAP, INC operates as a commercial manufacturer, their products are commonly integrated into federal healthcare systems, including VA medical centers and DoD clinical facilities, though direct contract data is not accessible to validate these relationships. The primary NAICS code 339112 indicates active involvement in surgical and medical instrument manufacturing, a niche requiring rigorous quality control, design validation, and adherence to ANSI/AAMI standards. The company’s market positioning is that of a specialized supplier to hospitals and integrated delivery networks, with an emphasis on durable, reusable, and single-use surgical devices that meet clinical workflow demands. AESCULAP, INC is structured as a 2L entity, indicating a small business classification under federal contracting rules, with its headquarters located in Center Valley, Pennsylvania. While no government certifications such as 8(a), HUBZone, or WOSB are listed, the company maintains commercial quality systems aligned with global medical device regulatory requirements. Their geographic presence is concentrated in the mid-Atlantic region, with distribution networks supporting federal and civilian healthcare markets nationwide.